VR Logo

Divi's Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1990

Chairman: Ramesh BV Nimmagadda

Managing Director: Murali K Divi

Group: Divis Labs

Listing: NSE: DIVISLAB, BSE: 532488

Headquarters: Hyderabad, Telangana

Website: www.divislaboratories.com

Key Facts

Market cap: R 96,112.90 Cr

Revenue (TTM): R 6,265.74 Cr

Earnings (TTM): R 1,758.97 Cr

Cash: R 1,093.98 Cr

Total Debt: R 33.63 Cr

Promoters' ownership: 51.96%

Liquidity: High

52 Week range: R 1,626.00 - 3,770.00

Face value: R2.00

Shares outstanding: 26,54,68,580

10 Years Aggregate:

  • CFO: 7,662.29 Cr
  • EBITDA: 12,014.24 Cr
  • Net Profit: 8,981.90 Cr

Stock Performance

Time Period Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
YTD96.168.2553.45
1 month15.2412.737.00
3 months12.0614.799.93
1 Year101.549.3950.97
3 Years51.7510.7814.13
5 Years26.0611.274.57
10 Years27.588.4411.91
As on 01-Dec-2020
Year Divi's Laboratories S&P BSE Sensex S&P BSE Healthcare
201925.1014.38-3.55
201834.775.87-5.89
201740.1527.910.49
2016-32.581.95-12.88
201532.33-5.0315.06
201440.4429.8947.43
201311.218.9822.55